ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Ventricular Assist Devices Are Associated with HLA but NOT MICA Allosensitization

    M. Askar, E. Hsich, P. Reville, J. Daghstani, A. Nowacki, S. Bakdash, A. Zhang, L. Klingman, W. Baldwin, N. Smedira, D. Taylor, R. Starling, G. Gonzalez-Stawinski

    Cleveland Clinic, Cleveland; Baylor Univeristy, Dallas

    Ventricular assist device (VAD) is implicated in HLA-sensitization. We investigate the association between VAD and HLA & MICA sensitization.Of all VAD patients studied (00-09); 89…
  • 2013 American Transplant Congress

    ABO Incompatible Kidney Transplantation Using Subcutaneous Alemtuzumab for Induction and No Post Transplant Plasmapheresis

    R. Villicana, J. Kahwaji, A. Peng, R. Najjar, S. Jordan, A. Vo

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    Introduction: Blood group incompatibility (ABOi) is a significant barrier to living donor (LD) kidney transplantation (ktx). We describe our ABOi kidney tx desensitization protocol which…
  • 2013 American Transplant Congress

    Is Liver Transplantation Outcome Worse for HCC Patients Using Organ Donation after Cardiac Death?

    G. El-Gazzaz, K. Hashimoto, C. Quintini, D. Kelly, C. Winans, B. Eghtesad, F. Aucejo, K. Abu-Elmagd, J. Fung, C. Miller

    Liver Transplant, Cleveland Clinic Foundation, Cleveland, OH

    BACKGROUNDDonation after cardiac death (DCD) has been used as potential way to increase donor liver availability. The aim of this study was to compare early…
  • 2013 American Transplant Congress

    Oral Ribavirin Therapy for Respiratory Syncytial Virus Infections in Moderately to Severely Immunocompromised Patients

    J. Marcelin, J. Wilson, R. Razonable

    Mayo Clinic, Rochester, MN

    BackgroundRespiratory syncytial virus (RSV) can be fatal in immunocompromised patients. Aerosolized ribavirin is used for treatment but it is costly, teratogenic, and inconvenient. We aimed…
  • 2013 American Transplant Congress

    Utilization of Kidneys from Donors after Circulatory Death in China: An Initial Report from a Single Center

    G. Chen, D. Ko, C. Wang, J. Qiu, M. Han, X. He, L. Chen

    Organ Transplant Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China; Departments of Urology and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    In 2007, a landmark decision that is supported by the international transplant community, the Chinese national government has established regulations to gradually abolish the use…
  • 2013 American Transplant Congress

    Outcomes of Switching to Belatacept from a Calcineurin Inhibitor in Kidney Transplant Recipients: 3 Year Results from the Long-Term Extension of a Phase II Study

    J. Grinyo, M. Rial, J. Alberu, S. Steinberg, R. Manfro, G. Nainan, F. Vincenti, C. Jones-Burton, N. Kamar

    Hosp Univ de Bellvitge, Spain; Inst de Nefrologia, Argentina; Inst Nacional de Ciencias Medicas y Nutricion, Mexico; Balboa Inst of Transpl, CA; Hosp de Clinicas de Porto Alegre, Brazil; Lakeshore Hosp, India; UCSF, CA; BMS, NJ; University Hosp, France

    Introduction: There remains a need for immunosuppressive agents which offer long-term preservation of renal function and an acceptable safety profile in the switch setting. Here…
  • 2013 American Transplant Congress

    Polyoma BK-Virus-Specific T Cells as a Surrogate Marker for Polyomavirus-Associated Nephropathy after Pediatric Kidney Transplantation

    T. Ahlenstiel, U. Sester, H. Fehrenbach, L. Pape

    Pediatric Nephrology, Hannover Medical School, Hannover, Germany; Nephrology and Hypertension, University of the Saarland, Homburg (Saar), Germany; Pediatrics, Klinikum Memmingen, Memmingen, Germany

    After kidney transplantation (KTx) immunosuppressive therapy causes impaired cellular immune defense resulting in increased risk of polyomavirus-associated nephropathy (PVAN). Prognostic markers for the outcome of…
  • 2013 American Transplant Congress

    Rat Liver Allo-Graft Rejection Promotes Anti-Cancer Immunity: A Model of Transplantation for Hepatocellular Carcinoma

    S. Lacotte, G. Oldani, L. Rubbia-Brandt, F. Slits, L. Orci, P. Morel, G. Mentha, C. Toso

    Surgery, University Geneva Hospital, Geneva, Switzerland; Pathology, University Geneva Hospital, Geneva, Switzerland

    Background: Liver transplantation for hepatocellular carcinoma (HCC) results in a specific condition where the immune response is directed both against allogeneic and cancer antigens. This…
  • 2013 American Transplant Congress

    Morphometric Age as a Predictor of Post Liver Transplant Survival

    S. Waits, E. Kim, M. Terjimanian, L. Tishberg, C. Harbaugh, C. Sonnenday, M. Englesbe

    General Surgery, Division of Transplant Surgery, University of Michigan, Ann Arbor

    INTRODUCTION: Better measures of pre-operative risk stratification are needed in liver transplantation. A cornerstone of a surgeon’s clinical assessment is best described as the “eyeball…
  • 2013 American Transplant Congress

    Natural Regulatory T-Cells Impair the Donor-Specific Cytotoxic T-Cell Response Long after Transplantation

    N. van Besouw, R. de Kuiper, M. Klepper, M. Betjes, W. Weimar, C. Baan

    Internal Medicine - Transplantation, Erasmus MC, Rotterdam, Netherlands

    Introduction: CD4+CD25highCD127- are potent regulators of cytokine production and proliferation of alloreactive T-cells. Although, cytotoxic T-cells are the effector cells that destroy the allograft. The…
  • « Previous Page
  • 1
  • …
  • 1638
  • 1639
  • 1640
  • 1641
  • 1642
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences